Biotechnology
11 articles
CRISPR yields climate-resilient crops, boosting food security
In 2021, Japan quietly introduced the world's first CRISPR-edited tomato, the Sicilian Rouge High GABA, engineered not just for resilience but enhanced nutritional content.
What is CRISPR Gene Editing and Why is it Revolutionizing Medicine?
In February 2025, KJ Muldoon became the first person to receive a personalized CRISPR therapy for a life-threatening metabolic disorder, according to Nature .
Stripe, Anthropic, OpenAI Launch $500M Fund to Fight Respiratory Infections
Stripe, Anthropic, and OpenAI lead a coalition of backers, including Flu Lab, the OpenAI Foundation, Bill Gates, and Jane Street Capital traders, in Intercept: a new $500 million fund aiming to elimin
Cellular reprogramming reverses aging markers in lab
Scientists recently reversed cellular aging markers in human skin cells by 30 years in a lab dish.
AI Accelerates Whole Body Rejuvenation Drug Discovery for Healthspan
David Sinclair plans to launch human tests of an oral 'reprogramming' drug as part of a $101 million XPrize competition, according to MIT Technology Review .
David Sinclair's Company Gets FDA Nod for Rejuvenation Trial
Life Biosciences, co-founded by prominent longevity researcher David Sinclair, has received FDA approval to begin the first human trial for a 'rejuvenation treatment' called ER-100.
How CRISPR Gene Editing Technology Works Explained
CRISPR–Cas9 and related technologies have successfully cured life-threatening diseases, created coronavirus detection tests, and modified human embryo cells, according to crispr-cas systems: overview,
How AI is Transforming Pharma Discovery and Development by 2034
In just five years, regulatory submissions containing AI/ML components in the pharmaceutical industry surged from 1 in 2016 to 132 in 2021, according to pmc .
Ebola outbreak control challenges mount with Bundibugyo species spread
The current Ebola outbreak in the Democratic Republic of the Congo and Uganda silently spread for weeks before a nurse, the first known case, developed symptoms on April 24, according to BBC .
Roche Acquires PathAI, Betting Big on AI Early Disease Detection
Roche is set to acquire PathAI for an upfront payment of $750 million, with potential milestone payments pushing the total past $1 billion, The Wall Street Journal reports.
How CRISPR Gene Editing Works: Revolutionizing Medicine
In a groundbreaking clinical trial, 29 out of 31 patients treated with Casgevy for sickle cell disease were freed from severe pain for at least a year.